Some retrospective studies indicate that overexpressions of NF-κB downstream effector proteins (e.g., VEGF, MMP-9, cyclin-D1, and XIAP) in cancer cells portend poorer survival for HCC patients [9, 10]. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.